Jacobson TA - Search Results

1

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.

Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ, Bruckert E, Jacobson TA, Kopecky SL, Baccara-Dinet MT, Du Y, Pordy R, Gipe DA; ODYSSEY ALTERNATIVE Investigators. Moriarty PM, et al. Among authors: jacobson ta. J Clin Lipidol. 2015 Nov-Dec;9(6):758-769. doi: 10.1016/j.jacl.2015.08.006. Epub 2015 Aug 29. J Clin Lipidol. 2015. PMID: 26687696 Free article. Clinical Trial.

2

Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.

Jacobson TA, Chin MM, Curry CL, Miller V, Papademetriou V, Schlant RC, LaRosa JC. Jacobson TA, et al. Arch Intern Med. 1995 Sep 25;155(17):1900-6. Arch Intern Med. 1995. PMID: 7677557 Clinical Trial.

3

Fluvastatin and niacin in hypercholesterolemia: a preliminary report on gender differences in efficacy.

Jacobson TA, Jokubaitis LA, Amorosa LF. Jacobson TA, et al. Am J Med. 1994 Jun 6;96(6A):64S-68S. doi: 10.1016/0002-9343(94)90234-8. Am J Med. 1994. PMID: 8017469 Clinical Trial.

4

Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease.

Jacobson TA. Jacobson TA. Curr Opin Lipidol. 1997 Dec;8(6):369-74. doi: 10.1097/00041433-199712000-00008. Curr Opin Lipidol. 1997. PMID: 9412778 Review.

5

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA. Harper CR, et al. Among authors: jacobson ta. Curr Opin Lipidol. 2007 Aug;18(4):401-8. doi: 10.1097/MOL.0b013e32825a6773. Curr Opin Lipidol. 2007. PMID: 17620856 Review.

6

Statin-induced myopathy: a review and update.

Abd TT, Jacobson TA. Abd TT, et al. Among authors: jacobson ta. Expert Opin Drug Saf. 2011 May;10(3):373-87. doi: 10.1517/14740338.2011.540568. Epub 2011 Feb 23. Expert Opin Drug Saf. 2011. PMID: 21342078 Review.

7

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Davidson MH, et al. Among authors: jacobson ta. J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005. J Clin Lipidol. 2011. PMID: 21981835

8

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.

Jacobson TA, Glickstein SB, Rowe JD, Soni PN. Jacobson TA, et al. J Clin Lipidol. 2012 Jan-Feb;6(1):5-18. doi: 10.1016/j.jacl.2011.10.018. Epub 2011 Nov 3. J Clin Lipidol. 2012. PMID: 22264569 Review.

9

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

Cohen JD, Brinton EA, Ito MK, Jacobson TA. Cohen JD, et al. Among authors: jacobson ta. J Clin Lipidol. 2012 May-Jun;6(3):208-15. doi: 10.1016/j.jacl.2012.03.003. J Clin Lipidol. 2012. PMID: 22658145 Free article.

10

Achieving adherence to lipid-lowering regimens.

Brown WV, Jacobson TA, Braun LT. Brown WV, et al. Among authors: jacobson ta. J Clin Lipidol. 2013 Jan-Feb;7(1):4-13. doi: 10.1016/j.jacl.2012.11.004. Epub 2012 Dec 21. J Clin Lipidol. 2013. PMID: 23351577 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page